We are live on ! Find out more
BC

Brinker Capital Portfolio holdings

AUM $3.13B
1-Year Est. Return 9.04%
This Fund
S&P 500
This Quarter Est. Return
+21.71%
1 Year Est. Return
+9.04%
3 Year Est. Return
+36.1%
5 Year Est. Return
+56.66%
10 Year Est. Return
AUM
$3.13B
AUM Growth
+$624M
Cap. Flow
+$133M
Cap. Flow %
4.25%
Top 10 Hldgs %
23.47%
Holding
1,002
New
95
Increased
529
Reduced
305
Closed
72

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.66%
2 Technology 15.39%
3 Healthcare 11.95%
4 Financials 8.26%
5 Industrials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABEV icon
876
Ambev
ABEV
$44.1B
$232K 0.01%
87,889
-18,473
-17% -$43.6K
BRKL
877
DELISTED
Brookline Bancorp
BRKL
$231K 0.01%
22,932
-1,279
-5% -$12.8K
LUMN icon
878
Lumen
LUMN
$6.23B
$230K 0.01%
22,958
+4,017
+21% +$40.2K
DE icon
879
Deere & Co
DE
$170B
$229K 0.01%
+1,456
New +$211K
VKTX icon
880
Viking Therapeutics
VKTX
$3.75B
$229K 0.01%
31,712
+1,811
+6% +$12K
TBCH
881
Turtle Beach Corp
TBCH
$223M
$229K 0.01%
15,591
-2,185
-12% -$22.5K
CUBE icon
882
CubeSmart
CUBE
$9.01B
$227K 0.01%
8,408
+52
+0.6% +$1.37K
ESE icon
883
ESCO Technologies
ESE
$7.18B
$226K 0.01%
2,679
-66
-2% -$5.21K
PAC icon
884
Grupo Aeroportuario del Pacifico
PAC
$12.4B
$225K 0.01%
+3,108
New +$198K
WRK
885
DELISTED
WestRock Company
WRK
$225K 0.01%
+7,958
New +$226K
REG icon
886
Regency Centers
REG
$13.8B
$223K 0.01%
4,867
-1,458
-23% -$61.6K
KRTX
887
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$221K 0.01%
+1,981
New +$172K
CUZ icon
888
Cousins Properties
CUZ
$4.85B
$218K 0.01%
7,315
-779
-10% -$23.4K
HZNP
889
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$218K 0.01%
+3,929
New +$168K
QGEN icon
890
Qiagen
QGEN
$8.9B
$217K 0.01%
4,771
-32,724
-87% -$1.46M
TLK icon
891
Telkom Indonesia
TLK
$14.4B
$214K 0.01%
9,797
-1,485
-13% -$31.4K
ROKU icon
892
Roku
ROKU
$23.4B
$213K 0.01%
+1,830
New +$209K
FWRD icon
893
Forward Air
FWRD
$574M
$212K 0.01%
4,262
-152
-3% -$7.46K
DIOD icon
894
Diodes
DIOD
$4.05B
$211K 0.01%
+4,155
New +$199K
CTVA icon
895
Corteva
CTVA
$56B
$209K 0.01%
+7,797
New +$203K
TRMB icon
896
Trimble
TRMB
$14.2B
$209K 0.01%
+4,849
New +$182K
GMED icon
897
Globus Medical
GMED
$11.1B
$205K 0.01%
+4,297
New +$207K
DCPH
898
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$205K 0.01%
+3,437
New +$184K
WPX
899
DELISTED
WPX Energy, Inc.
WPX
$204K 0.01%
32,041
-2,508
-7% -$14.1K
LII icon
900
Lennox International
LII
$13.6B
$203K 0.01%
871
-3,988
-82% -$805K

Similar funds

Brinker Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Brinker Capital held 1,002 positions worth $3.13B, up 25% from $2.51B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Brinker Capital deployed $133M of net new capital in Q2 2020, opening 95 new positions and adding to 529 existing holdings. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 282,435 shares worth $15.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Schwab Short-Term US Treasury ETF, an estimated $29.5M trimmed.

  • Brinker Capital's largest Q2 2020 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 282,435 shares worth $15.5M.
  • Brinker Capital added most to Vanguard Short-Term Corporate Bond ETF in Q2 2020, an estimated $9.82M increase.
  • Brinker Capital's biggest Q2 2020 reduction was Schwab Short-Term US Treasury ETF, cutting an estimated $29.5M.
  • Brinker Capital fully exited iShares Intermediate Government/Credit Bond ETF in Q2 2020, selling an estimated $14.6M.
  • Brinker Capital's ten largest holdings make up 23% of its $3.13B portfolio in Q2 2020.
  • Brinker Capital opened 95 new positions and closed 72 in Q2 2020.
  • Brinker Capital's portfolio value rose 25% quarter-over-quarter to $3.13B.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.